InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (16 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
16
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Valliant John, Chairman & CEO. Director active across 1 company, notably Fusion Pharmaceuticals Inc.. Cumulatively, 17 reports have been published. Breakdown: 0 buy · 16 sells. Total volume traded: €295k. Activity tracked since 15 February 2022. The latest transaction was filed on 25 April 2022 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Valliant John
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations17 total
318,147 sharesCommon StockSEC:0000950170-24-068905:0
2,036 shares@ US$6.033.0% of flowCommon StockSEC:0001209191-22-025783:0
367 shares@ US$6.020.5% of flowCommon StockSEC:0001209191-22-025469:0
2,600 shares@ US$7.374.5% of flowCommon StockSEC:0001209191-22-024330:0
100 shares@ US$7.580.2% of flowCommon StockSEC:0001209191-22-023861:0
1,000 shares@ US$7.751.8% of flowCommon StockSEC:0001209191-22-023124:0
300 shares@ US$7.520.5% of flowCommon StockSEC:0001209191-22-022034:0
500 shares@ US$7.420.9% of flowCommon StockSEC:0001209191-22-021487:0
4,000 shares@ US$7.537.0% of flowCommon StockSEC:0001209191-22-020948:0
900 shares@ US$7.511.6% of flowCommon StockSEC:0001209191-22-020316:0
1,300 shares@ US$6.962.1% of flowCommon StockSEC:0001209191-22-019224:0
822 shares@ US$6.941.3% of flowCommon StockSEC:0001209191-22-018455:0
8,400 shares@ US$7.3214.3% of flowCommon StockSEC:0001209191-22-017150:0
847 shares@ US$7.371.4% of flowCommon StockSEC:0001209191-22-015555:0
2,500 shares@ US$7.414.2% of flowCommon StockSEC:0001209191-22-013791:0
4,898 shares@ US$7.888.7% of flowCommon StockSEC:0001209191-22-012344:0
12,600 shares@ US$8.3323.9% of flowCommon StockSEC:0001209191-22-010918:0
17 of 17 declarations
About Valliant John
Valliant John is an insider at Fusion Pharmaceuticals Inc.
